Showing 81-90 of 3001 results for "".
A Treatment Within
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-treatment-within/30713/A small Phase I trial sees success using patients' own altered blood cells to fight immune responses in MS. Is this the future of MS therapy?An Overview of Neuropsychiatric Symptoms, Clinical Features, and Management Options for Individuals Living with Multiple Sclerosis
https://practicalneurology.com/archives/aug-2025-issue/an-overview-of-neuropsychiatric-symptoms-clinical-features-and-management-options-for-individuals-living-with-multiple-sclerosis/36690/Recognizing psychiatric manifestations, understanding their origin, and providing proper treatment are imperative to comprehensive care of people living with MS.Therapeutics Q&A:
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/therapeutics-qa/30861/The first drug approved specifically to manage a symptom of MS is shown to improve patients' walking ability.Ocrelizumab and the Next Phase in Multiple Sclerosis Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ocrelizumab-and-the-next-phase-in-multiple-sclerosis-therapy/30505/Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.Multiple Sclerosis--Is it One Disease or Many Diseases?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-is-it-one-disease-or-many-diseases/30103/Dr. Stephen Krieger will share his view that MS is one disease state while Dr. Bianca Weinstock-Guttman challenges that view, arguing that MS is many disease states.Diagnostic Q&A: Optical Coherence Tomography and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/diagnostic-qa-using-optical-coherence-tomography-to-diagnose-multiple-sclerosis/30823/New findings suggest a novel in-office imaging technique can help identify MS patients who are likely to have increased disease severity. An investigator explains.Pediatric-Onset Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pediatric-onset-multiple-sclerosis/30128/Information from clinical trials in children with MS is furthering understanding and improving treatment options for this rare presentation.Promising Directions in Relapse-Impact Prevention in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/promising-directions-in-relapse-impact-prevention-in-multiple-sclerosis/30520/Current immunomodulatory treatments for MS are not reliable to prevent long-term disability, but future agents focusing on remyelination and axonal and neuronal repair could reverse this course.Relapsing and Progressive Multiple Sclerosis: Understanding the Differences
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapsing-and-progressive-multiple-sclerosis-understanding-the-differences/30761/Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.Vitamin D: Considerations for Treatment, Prevention, and Risk in Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/vitamin-d-considerations-for-treatment-prevention-and-risk-in-multiple-sclerosis-care/30373/Preliminary signals are strong that vitamin D has a role to play in MS, but more research is needed to confirm the need for supplementation as a preventive or therapeutic measure.